Actionable Renal Dosing Content for Nephrotoxic Medications in 4 Drug Information Resources Commonly Used in the United States.

IF 1.1 Q4 PHARMACOLOGY & PHARMACY
Heather Ipema, Erika Maslennikov, Faria Munir, Patricia Hartke, Ruba Alomari, Anna Dazy, Alexandra Wierzbiak
{"title":"Actionable Renal Dosing Content for Nephrotoxic Medications in 4 Drug Information Resources Commonly Used in the United States.","authors":"Heather Ipema, Erika Maslennikov, Faria Munir, Patricia Hartke, Ruba Alomari, Anna Dazy, Alexandra Wierzbiak","doi":"10.1177/08971900251364049","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> Inclusion of numeric, actionable renal dosing recommendations in drug information resources enhances the safe use of nephrotoxins. <b>Purpose:</b> The purpose of this study was to systematically and descriptively characterize the renal dose recommendations for nephrotoxic medications in 4 common drug information resources. <b>Methods:</b> A list of nephrotoxins (N = 154) was generated from previously published lists. Renal dosing information was collected for each drug from the package insert, Lexi-comp (now called UpToDate Lexidrug), Micromedex, and Clinical Pharmacology. Dosing recommendations were categorized using a previously published 6-category scale based on whether recommendations were included vs missing, and numeric vs non-numeric. <b>Results:</b> Actionable renal impairment recommendations (numeric, non-numeric, contraindicated, no dose adjustment required) in the package insert, Lexi-comp, Micromedex, and Clinical Pharmacology were present for 88.3%, 98.1%, 94.2%, and 98.1% of drugs, respectively. Numeric recommendations were available for 54.5% to 75.3% of medications, depending on the source. Actionable recommendations for hemodialysis, peritoneal dialysis, continuous renal replacement, and hybrid dialysis modalities were more common in Lexi-comp (83.1%, 75.3%, 62.3%, and 53.9% of medications, respectively) vs the other resources. Actionable pediatric renal impairment (76.0%) and older adult (95.5%) recommendations were also more common in Lexi-comp than other resources. <b>Conclusions:</b> Drug information resources included actionable renal dosing recommendations for most known nephrotoxins, with Lexi-comp being most likely to include this information. Numeric and/or actionable recommendations for specific dosing populations (eg, renal replacement modalities, pediatric renal impairment, older adults) were generally lacking. Lack of agreement among resources suggests a need to check multiple sources in practice.</p>","PeriodicalId":16818,"journal":{"name":"Journal of pharmacy practice","volume":" ","pages":"8971900251364049"},"PeriodicalIF":1.1000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmacy practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/08971900251364049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Inclusion of numeric, actionable renal dosing recommendations in drug information resources enhances the safe use of nephrotoxins. Purpose: The purpose of this study was to systematically and descriptively characterize the renal dose recommendations for nephrotoxic medications in 4 common drug information resources. Methods: A list of nephrotoxins (N = 154) was generated from previously published lists. Renal dosing information was collected for each drug from the package insert, Lexi-comp (now called UpToDate Lexidrug), Micromedex, and Clinical Pharmacology. Dosing recommendations were categorized using a previously published 6-category scale based on whether recommendations were included vs missing, and numeric vs non-numeric. Results: Actionable renal impairment recommendations (numeric, non-numeric, contraindicated, no dose adjustment required) in the package insert, Lexi-comp, Micromedex, and Clinical Pharmacology were present for 88.3%, 98.1%, 94.2%, and 98.1% of drugs, respectively. Numeric recommendations were available for 54.5% to 75.3% of medications, depending on the source. Actionable recommendations for hemodialysis, peritoneal dialysis, continuous renal replacement, and hybrid dialysis modalities were more common in Lexi-comp (83.1%, 75.3%, 62.3%, and 53.9% of medications, respectively) vs the other resources. Actionable pediatric renal impairment (76.0%) and older adult (95.5%) recommendations were also more common in Lexi-comp than other resources. Conclusions: Drug information resources included actionable renal dosing recommendations for most known nephrotoxins, with Lexi-comp being most likely to include this information. Numeric and/or actionable recommendations for specific dosing populations (eg, renal replacement modalities, pediatric renal impairment, older adults) were generally lacking. Lack of agreement among resources suggests a need to check multiple sources in practice.

美国常用的4种药物信息资源中肾毒性药物可操作的肾脏剂量含量。
在药物信息资源中纳入数字的、可操作的肾脏剂量建议,增强了肾毒素的安全使用。目的:本研究的目的是系统、描述性地描述4种常用药物信息资源中肾毒性药物的推荐剂量。方法:根据先前公布的肾毒素清单生成肾毒素清单(N = 154)。从包装说明书、Lexi-comp(现在称为UpToDate lexiddrug)、Micromedex和临床药理学中收集每种药物的肾脏剂量信息。使用先前发布的6类量表对剂量建议进行分类,该量表基于建议是否包括和缺失,以及数字和非数字。结果:在药品说明书、Lexi-comp、Micromedex和临床药理学中,分别有88.3%、98.1%、94.2%和98.1%的药物存在可操作的肾脏损害建议(数字、非数字、禁忌症、不需要调整剂量)。根据来源的不同,54.5%至75.3%的药物可获得数字建议。与其他资源相比,Lexi-comp对血液透析、腹膜透析、持续肾脏替代和混合透析方式的可操作建议更常见(分别为83.1%、75.3%、62.3%和53.9%的药物)。可操作的儿童肾脏损害(76.0%)和老年人(95.5%)建议在Lexi-comp中也比其他资源更常见。结论:药物信息资源包括大多数已知肾毒素可操作的肾脏剂量建议,Lexi-comp最有可能包括这一信息。一般缺乏针对特定给药人群(如肾脏替代方式、儿童肾脏损害、老年人)的数字和/或可操作的建议。资源之间缺乏一致性表明在实践中需要检查多个来源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of pharmacy practice
Journal of pharmacy practice PHARMACOLOGY & PHARMACY-
CiteScore
3.20
自引率
7.70%
发文量
184
期刊介绍: The Journal of Pharmacy Practice offers the practicing pharmacist topical, important, and useful information to support pharmacy practice and pharmaceutical care and expand the pharmacist"s professional horizons. The journal is presented in a single-topic, scholarly review format. Guest editors are selected for expertise in the subject area, who then recruit contributors from that practice or topic area.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信